|
|
||||||
|
|||||||
Neuropeptide
effect on splenocytes modifies ovarian steroidogenesis SECRETION FROM NEUROPEPTIDE-TREATED SPLENOCYTES
MODIFIES OVARIAN STEROIDOGENESIS LILIANA OLIVEROS, MYRIAM FORNERIS, LUIS AGUADO* Laboratorio de Biología de la Reproducción, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, San Luis
Resumen Secreciones de esplenocitos tratados con neuropéptidos modifican la esteroidogénesis ovárica. Algunas evidencias indican que la función inmune está regulada por el sistema nervioso simpático y su neurotransmisor principal, norepinefrina (NE), a través del sistema nervio ovárico superior (NOS)-ganglio celíaco-inervación posganglionar noradrenérgica del bazo. En el presente trabajo, se seccionó el NOS a ratas de 53 días de edad y se sacrificaron los animales siete días más tarde (60 días de edad). Se aislaron los esplenocitos del bazo y se cultivaron por 48 hs. Se trabajó paralelamente con ratas controles (con operación simulada). El medio de cultivo se usó para estimular ovarios de ratas intactas de 60 días en diestro 2 (sin el NOS seccionado o con operación simulada) en incubaciones in vitro. Se observó disminución de la progesterona y aumento del estradiol liberados por el ovario, en relación al efecto producido por el medio de cultivo de esplenocitos de ratas controles. Cuando los esplenocitos de ratas con el NOS seccionado (NOS-s) fueron tratados con péptido intestinal vasoactivo (VIP) o con neuropéptido Y (NPY), 10-6M durante 24 h, sus secreciones incrementaron la liberación de progesterona, mientras que disminuyeron la de estradiol, desde ovarios intactos, comparado con las secreciones de los esplenocitos no tratados de ratas NOS-s. Las secreciones de esplenocitos tratados con VIP disminuyeron la liberación de androstenodiona desde ovarios intactos, mientras que con NPY no se observaron cambios significativos. La respuesta esteroidogénica ovárica, que fue modificada por los efectos de la sección del NOS sobre las células del bazo, fue revertida cuando los esplenocitos de ratas NOS-s fueron tratados in vitro con VIP or NPY. Esto sugiere que la sección del NOS disminuye la llegada de VIP y NPY al bazo. Cuando se adicionan dichos neuropéptidos a los esplenocitos en cultivo, las secreciones de estas células revierten el perfil de las hormonas liberadas por ovarios intactos. En este trabajo también se muestra evidencia de la modulación de la función inmune por el sistema nervioso simpático y por neurotransmisores distintos a NE. Palabras clave: esplenocitos, péptido intestinal, vasoactivo, neuropéptido Y, esteroidogénesis ovárica
Abstract There are evidences for modulation of immune function by the sympathetic nervous system and its principal neurotransmitter norepinephrine (NE) through superior ovarian nerve (SON)-coeliac ganglion-noradrenergic postganglionic innervation of the spleen. Seven days after SON transection at 53 days of age, the rat splenocytes were isolated and then cultured for 48 h. These culture media, used to stimulate ovaries from 60-day-old intact rats (neither SON-transected nor sham-operated) at diestrus 2 stage, in in vitro incubations, showed a decrease in progesterone release, an increase in estradiol release and no change in androstenedione release in relation to splenocyte culture media from control (sham-operated) rats. When esplenocytes from SON transected (SON-t) rats were treated with vasoactive intestinal peptide (VIP) or neuropeptide Y (NPY), both at 10-6M for 24 h, their secretions increased the progesterone release while decreasing the estradiol release from the intact ovaries, compared with the secretions of untreated splenocytes from SON-t rats. Although the secretions of splenocytes treated with VIP decrease the androstenedione release from the ovaries, the treatment with NPY produced no change in hormone release. In the present paper the ovarian steroidogenic response, which was modified by the effects of an in vivo SON transection on spleen cells, was reverted by an in vitro system in which the splenocytes were treated with VIP or NPY. This could indicate that the spleen of SON-t rats does not receive those neuropeptides by neural route however, when they are added to splenocyte culture in vitro, the cell secretions revert the profile of steroid hormones released from the intact ovary. We also present functional evidence for modulation of the immune function by sympathetic nervous system and neurotransmitters other than NE. Key words: splenocytes,
vasoactive intestinal peptide, neuropeptide Y, ovarian
steroidogenesis.
Communication
between the neuroimmune and endocrine systems and a reciprocal flow
of information are suggested by several observations1.
It is known that sympathetic noradrenergic (NA) nerve fibers and
sensory neurons inervate immune organs such as the spleen, the
thymus, the lymph nodes and gut-associated lymphoid tissues2-4.
On the other hand, the ability of various hormones to affect immune
functions in vivo and in vitro has long been known. An
elevation of adrenal glucocorticoids during stress has been
considered to be responsible for stress-induced immunosuppression5.
LH, FSH, PRL, GH, TSH, among others, have been shown to modulate the
immune response6,
7. The
noradrenergic postganglionic innervation of rat spleen originates
mainly in the superior mesenteric/coeliac ganglion and the nerve
fibers enter the spleen at the hilar region with the vasculature8, 9.
Electron microscopic immunocytochemical studies of tyrosine
hydroxylase nerve fibers have shown direct contacts of nerve
terminals with lymphocytes and macrophages in the spleen10.
The endings of these nerves contain norepinephrine (NE), and, among
other neuropeptides, vasoactive intestinal peptide (VIP) and
neuropeptide Y (NPY)11, 12.
The presence of NE, VIP
and NPY receptors in rat splenic lymphocytes has been demonstrated12-14.
The reduction in splenic NA innervation is associated with
degeneration of NA nerve fibers and ultimately, with loss of their
cell bodies in the superior mesenteric/coeliac ganglionic complex15.
On
the other hand, it is known that the superior ovarian nerve (SON),
which innervates the ovary, has its preganglionic cell bodies in the
spinal cord16.
These exit at thoraco spinal cord at levels T10 and T11 and synapse
in neurons of coeliac and suprarrenal ganglia. It has been
demonstrated that the SON contains mainly afferent and efferent
noradrenergic (NA) fibers and also vipiergic fibers from the coeliac
ganglion17-19. SON transection in adult rats affects splenocyte secretions, which
participate in the ovarian steroidogenic response, particularly in
progesterone release, which secretions might be controlled by
adrenergic influences since the number of splenocyte b-adrenergic
receptors changes through SON-coeliac ganglion-noradrenergic
postganglionic innervation of the spleen20. There is almost no information
about the effect of SON transection on the spleen cells, which, like
the ovary, are also innervated extensively by afferent and efferent
noradrenergic sympathetic nerve fibers from the coeliac ganglion16,
17. The
aim of the present work was to study if the effects of an in vivo
SON transection on the spleen cells, determined by the effect of the
secretions of those cells on the steroidogenic response of intact
ovaries, could be reverted by an in vitro system in which the
splenocytes were treated with VIP or NPY, as we have previously done
with NE20.
Culture media of splenocytes from SON transected (SON-t) rats
and of those splenocytes treated with VIP or NPY were used to
stimulate intact ovaries. Materials
and Methods Chemicals. Liquid
culture medium, penicillin G, streptomycin, crude trypsin, soybean
trypsin inhibitor, VIP and NPY were purchased from Sigma Chemical Co
(St. Louis, MO, USA). Progesterone,
estradiol, androstenedione were provided by New England Nuclear
(Boston, MA, USA). All the other chemicals were of reagent grade and
were purchased from Merck Laboratory, Buenos Aires, Argentina. Animals
and experimental model.
Adult female Holtzman rats were used. They were housed in a
controlled environment (22-24 oC, 12 h light- 12 h dark). Water and food were available ad libitum.
Two groups of cyclic adult rats were used, one SON-transected
(SON-t) and the other one sham-operated (control) at 53 days of age.
Seven days after the SON transection was performed all rats were
killed and the splenocytes were isolated. The splenocytes from SON-t and
control rats were preincubated for 24 h, then, the medium was
removed and the cells were cultured for an additional 48 h. On the
other hand, splenocytes from SON-t rats were cultured in presence of
VIP in one case and NPY in another, both at 10-6 M, for 24 h. After that, the medium was replaced by fresh medium and
the splenocytes were cultured for an additional 24 h. Fluids
were collected and used to stimulate ovaries from 60-day-old intact
rats (neither SON-t nor sham-operated) rats in diestrus 2 stage, in in
vitro incubation to measure the steroidogenic response (Fig.1).
Considering the influence of SON transection on both the ovary and
the spleen, via the coeliac ganglion, in all the experiments carried
out, the effect of the culture medium from splenocytes was studied
on ovaries from intact rats. Transection
of the superior ovarian nerve. Rats were lightly anaesthetized with ether and the ovaries were exposed
through bilateral dorsal incisions. The SON transection was achieved
as described previously20. In brief, the suspensory ligament enclosing the SON was lifted with
fine forceps, the nerve was cut with
small scissors, the ovaries were returned to the abdominal
cavity, and the wounds were sutured. The suspensory ligament is
clearly visible and the SON travels along it, thus, we assumed that
transection of the suspensory ligament results in transection of the
SON. Splenocyte
cultures.
In brief, rats were killed by decapitation, their spleens were
aseptically removed, washed in saline solution and pressed through a
sterile nylon screen (200 mm mesh) to obtain individual splenocytes.
The cells were collected by centrifugation (600 g, 5 min,)
resuspended in serum-free RPMI medium and treated with 0.83% NH4Cl: 2.6% TRIS (9:1, v/v) pH 7.2, to remove the red blood cells. Cells (1
x 106 viable cells/ml of medium) were cultured in 8 x 75 mm
glass test tubes at 37 oC
in 95% air: 5% CO2
atmosphere.
The medium was supplemented with 10% fetal bovine serum and
antibiotics (50 mg/ml streptomycin and 50 units/ml
penicillin). Ovary
incubation.
After killing the intact rats, the ovaries were immediately removed,
dissected, weighed and preincubated in 1 ml of fresh culture medium
at 37 oC, in 95% O2: 5% CO2 mixture. After 30 min, the medium was discarded and 1 ml of splenocyte
culture medium was added. Incubation was continued for 3 h and then
the medium was removed and stored at -70 oC
for subsequent measurement of steroids. Steroid
assays.
The progesterone, estradiol and andros-tenedione contents of culture
media were determined by specific RIAs using antisera as described
previously21.
The assay sensitivity was
less than 5 ng/ml
for
progesterone, 12 fmole/tube for estradiol and 0.02 ng/ml for
androstenedione. The inter-
and intraassay coefficients of variation for all the assays were
less than 10.0%. Statistical
analyses.
Results are expressed as mean ± SEM. Significant differences among
means were considered at a level of P< 0.05 and tested by
Student’s t-test. Results The effect of secretions from splenocytes treated with neuropeptides on
the ovarian steroidogenesis is shown in the figures. The results
were expressed in all cases as ng or pg / mg ovary or / mg protein.
Fig. 2 shows the progesterone release from ovaries of control and
SON-t rats incubated with culture medium of splenocytes. When
culture medium of splenocytes from SON-t rats was used, the
progesterone release from ovaries decreased significantly in
relation to that observed when the splenocyte culture medium came
from control rats, p< 0.001. When splenocytes from SON-t rats
were treated with VIP or NPY, their secretions increased the
progesterone release from the ovaries (p< 0.001), compared with
the secretions from SON-t rats untreated splenocytes. The values
obtained in presence of neuropeptides reached the progesterone
levels released by the ovaries incubated with culture medium from
splenocytes of control rats (p< 0.001). As
shown in Fig. 3, the estradiol release from ovaries incubated with
culture medium of SON-t rat splenocytes without neuropeptide
treatment increased markedly in relation to that obtained with
culture medium of splenocytes from control rats, p< 0.001.
However, when culture
medium of SON-t rat splenocytes treated with VIP or NPY was used, a
significant decrease
(p< 0.001) in estradiol release from ovaries was observed,
compared with that from ovaries incubated with secretions of SON-t
rat untreated splenocytes. When
culture medium of splenocytes from SON-t rats was used, the
androstenedione release from ovaries did not change in relation to
that observed when the splenocyte culture medium derived from
control rats. Similar results were obtained
when splenocytes from SON-t rats were previously treated with
VIP. The secretions of splenocytes treated with NPY decreased (p<
0.001) the androstenedione release from the ovaries (Fig. 4). Discussion The ovary and spleen are innervated extensively by afferent and efferent
noradrenergic sympathetic
nerve fibers from the coeliac ganglion16, 17, 22, 23.
The endings of those nerves contain NE, VIP and NPY11, 12,
among other neurotransmitters. In particular, the coeliac
ganglion is connected through the superior ovarian nerve to the
ovary 16, 17, 24.
We have previously shown that the effects on the
splenocyte b-adrenergic receptors number after an in vivo SON transection were
simulated by an in vitro system modulating b-adrenergic receptors number by treatment of splenocytes from SON-t rats
with and without NE. Additionaly, we have observed that the change
in the ß-adrenergic receptors number was associated to a
change in the secretion of those splenocytes since ovaries from
intact rats incubated with those secretions modify their
steroidogenic response. It was suggested that the activity of
splenocytes could be controlled by adrenergic influences20.
In the present investigation we showed that the effects of an in
vivo SON transection on the splenocyte secretions could be
reverted by an in vitro system in which the splenocytes were
treated with VIP or NPY, as we have previously done with NE20.
We showed that the secretions of the cultured splenocytes from SON-t
rats produced a decrease of progesterone, an
increase of estradiol and no change in androste-nedione
release from intact
ovaries. It has been observed that circulating levels of IL-1 are
elevated during luteal phase of normally cycling women25.
Inversely, low concentrations of progesterone appear to upregulate
macrofage IL-1 gene expression, while higher concentrations of
progesterone significantly inhibit
IL-1 activity26.
In our case, low concentrations of progesterone were released from
the ovaries when they were incubated with secretions of the cultured
splenocytes from SON-t rats, suggesting that those secretions are
not the same as those of splenocytes from control rats. This fact
could be in agreement with the eventual participation of IL-1 in the
process. In an in vivo situation, there is no possibility
that high levels of progesterone affect the splenocyte secretions,
since the circulating progesterone levels did not change with the
SON transection (data not shown). We also show that splenocyte
secretions of SON-t rats stimulate estrogen release from the
ovaries, indicating that the SON transection modifies the splenocyte
secretions. It has been demonstrated in granulosa cells that the
steroidogenic activity of a factor obtained from the splenocytes of
normal animals could not be attributed to a FSH-like molecule. Those
authors suggest that that factor is different from FSH because it
does not contain FSH immunoreactivity nor does it contain FSH
receptor-binding activity27. It
is known that rat splenic lymphocytes possess VIP and NPY
receptors12-14.
In this paper we show evidence that splenocyte secretions, which
participate in the ovarian steroidogenic response, might be
controlled by VIP and NPY. We observed that culture medium of
SON-t rats, containing the secretions of VIP treated or NPY treated
splenocytes increased the progesterone release from the ovaries,
while the release of estradiol decreased, compared with the
secretions of untreated splenocytes. On the other hand, the
secretions of NPY treated
splenocytes decreased the androstenedione release from the ovaries,
but no change was observed when splenocytes were treated with VIP.
Probably, the decrease in estradiol release, when ovaries were
stimulated with secretions of splenocytes treated with NPY, could be
associated with the decrease in androstenedione release in the same
conditions, considering that androstenedione is a natural precursor
of estradiol. Recently, it has been shown that NPY greatly enhanced
IL-4 production and inhibited that of interferon-gamma (IFN-gamma)
from mouse helper T cell subsets. However, VIP had no effects on
IFN-gamma production, while it inhibited IL-4 production slightly
but consistently28.
It has been shown that the addition of nerve growth factor (NGF) to
unstimulated purified T cells induces the synthesis of NPY29. Thus, these neuropeptides modify the activity of the immune cells.
However, the effect of the immune system on ovarian steroidogenic
activity is still not clear. Considering
our previous report20 and the results presented in this study, we can speculate that the SON
transection could modify the coeliac ganglion, in a retrograde way,
affecting the release of VIP
and NPY through its sympathetic fibers to the spleen. This fact
could modify the splenocyte activity, probably by releasing specific
secretions which, as we have shown, influence the steroidogenic
response of intact ovaries. That steroidogenic response was reverted
when ovaries were incubated with culture medium of SON-t rats
splenocytes treated with VIP or NPY. The factor(s) secreted by
splenocytes might provide a link between intraovarian spleen cells
and the regulation of the ovarian function. It is known that
lymphocytes release specific cytokines which modulate granulosa cell
steroidogenesis, typically in an inhibitory30
and stimulatory fashion31,
but we cannot affirm that the ovarian steroidogenic-modulating
factor(s) produced by the splenocytes treated with VIP or NPY is
(are) a cytokine. The
relevance of the factor(s) secreted by the splenocytes to the
ovarian physiology remains a matter of study but, it is possible
that that secretion, either in the spleen or in the circulation,
could affect the ovarian function through an endocrine mechanism. On
the other hand, knowing that immune signals influence the
hypothalamic-pituitary axis32
it is possible that the factor(s) secreted by the splenocytes in the
intact animal could be released into the general circulation to act
on hypothalamic-pituitary sites and subsequently originate
modifications in the ovarian function. Acknowledgements:
This
work has been supported by Grants 3711/92 from CONICET (Consejo
Nacional de Investigaciones Científicas y Técnicas, Argentina) and
9302 from San Luis University, Argentina. References
1. Gaillard
RC. Neuroendocrine-immune system interactions. The
immune-hypothalamo-pituitary-adrenal axis. Trends Endocrinol
Metab 1994; 5: 303-9.
2. Madden
KS, Sanders VM, Felten DL. Catecholamine influences and sympathetic
neural modulation of inmune responsiveness. Annu Rev Pharmacol
Toxicol 1995; 35: 417-48.
3. Hori T,
Katafuchi T, Take S, Shimizu N, Niijima A. The autonomic nervous
system as a communication channel between the brain and the immune
system. Neuroimmu-nomodulation 1995; 2: 203-15. 4. Felten SY, Olschowka JA. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J Neurosci Res 1987; 18: 37-48. 5.
Wilcknes T. Glucocorticoids and immune function:
physiologycal relevance and pathogenic potential of hormonal
dysfunction. Tips 1995; 16: 193-7.
6. Rouabhia
M, Chakir J, Deschaux P. Interaction between the immune and
endocrine systems: immunomodulatory effects of luteinizing hormone. Prog
Neuroendocrinol Immunol 1991; 4: 86-91.
7. Weigent
DA, Blalock JE. Associations between the neuroendocrine and inmune
systems. J Leukoc Biol 1995; 57: 137-50.
8. Bellinger
DL, Felten SY, Lorton D, Felten DL. Origin of noradrenergic
innervation of the spleen in rats. Brain Behav Immunol 1989;
3: 291-311.
9. Nance DM,
Burns J. Innervation of the spleen in the rat: evidence for absence
of afferent innervation. Brain Behav Immunol 1989; 3: 218-30. 10.
Meltzer JC, Grimm PC, Greemberg AH, Nance DM. Enhanced
immunohistochemical detection of autonomic nerve fibers, cytokines
and inducible nitric oxide syntethase by light and fluorescent
microscopy in rat spleen. J Histochem Cytochem
1997; 45: 599-610. 11.
Romano TA, Felten SY, Felten DL, Olschowka JA. Neuropeptide-Y
innervation of the rat spleen: Another potential immunomodulatory
neuropeptide. Brain Behav Immun 1991; 5: 116-31. 12.
Goetzl EJ, Pankhaniya RR, Gaufo GO, MuY, Xia M, Sreedharan
SP. Selectivity of effects of vasoactive intestinal peptide on
macrophages and lymphocytes in compartmental immune responses. Neuroimmunomo-dulation
1998; 840: 540-50. 13.
Petitto JM, Huang Z, McCarthy DB. Molecular cloning of NPY-Y1
receptor cDNA from rat splenic lymphocytes: evidence of low levels
of mRNA expression and [125I]NPY
binding sites. J Neuroimmunol 1994; 54: 81-6. 14.
Schwarz H, Villinger PM, von Kempis J, Lotz M. Neuropeptide Y
is an inducible gene in the human immune system. J Neuroimmunol
1994; 51: 53-61. 15.
Santer RM, Partanen M, Hervonen A. Glyoxylic acid
fluorescence and ultraestructural studies of neurones in the
coeliac-superior mesenteric ganglion of the aged rat. Cell Tissue
Res 1980; 212: 475-85. 16.
Dissen GA, Dees WL, Ojeda SR. Neural and neurotropic control
of ovarian development. In: Adashi EY, Leung
PCK (eds): The Ovary. New York: Raven Press, 1993,
p 1-19 17.
Lawrence IE, Burden HW. The origin of the extrinsic
adrenergic innervation to the rat ovary. Anat Rec 1980; 196:
51-9. 18.
Burden HW, Leonard M, Smith CP, Lawrence IE Jr. The sensory
innervation of the ovary a horseradish peroxidase study in the rat. Anat
Rec 1982; 207: 623-7. 19.
Jarret WA, Price GT, Lynn VJ, Burden HW. NADPH-diaphorase
positive neurons innervating the rat ovary. Neurosci Lett
1994; 177: 45-9. 20.
Forneris M, Oliveros L, Aguado L. Effect of secretion of
splenocytes after superior ovarian nerve section on the ovarian
steroidogenesis. Neuroimmunomodulation 1999; 6: 293-9. 21.
Bussmann LE, Deis RP. Studies concerning the hormonal
induction of lactogenesis by prostalglandin F2a in pregnant rat. J
Steroid Biochem 1979; 11: 1485-9. 22. Felten DL, Ackerman KD, Wiegand SJ, Felten SY. Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J Neurosci Res 1987; 18: 28-36. 23.
Ackerman KD, Felten SY, Dijkstra CD, Livnat S, Felten DL.
Parallel development of noradrenergic innervation and cellular
compartmentation in the rat spleen. Exp Neurol 1989; 103:
239-55. 24.
Sosa ZY, Casais M, Rastrilla AM, Aguado L. Adrenergic
influences on coeliac ganglion affect the release of progesterone
from cycling ovaries. Characterization of an in vitro system. J
Endocrinol 2000; 166: 307-18. 25.
Cannon JG, Dinarello CA. Increased plasma interleukin-1
activity in women after ovulation. Science 1985; 227:
1247-54. 26.
Polan ML, Carding S, Loukides J. Progesterone modulates
interleukine-1b (IL-1b) mRNA production by human pelvic macrophages.
Fertil Steril 1988; 50: 54-67. 27.
Ness JM, Kasson BG. Stimulation of rat granulosa cell
progesterone production but not other differentiated functions by a
splenocyte-derived factor. J Reprod Fert 1995;
105:125-33. 28.
Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata
A, Yamamoto H. Differential effects of neuropeptides on cytokine
production by mouse helper T cell subsets. Neuroimmunomodulation
1998; 5: 9-15. 29.
Bracci Laudiero L, Aloe L, Stenfors C, Tirassa P, Theodorsson
E, Lundberg T. Nerve growth factor stimulates production of
neuropeptide Y in human lymphocytes. Neuroreport 1996; 7:
484-8. 30.
Gorospe WC, Hughes FM, Spangelo BL. Interleukin-6: effects on
and production by rat granulosa cell in vitro. Endocrinology
1992; 130: 1750-2. 31.
Gorospe WC, Kasson BG. Lymphokines from concanavalin
A-stimulated lymphocytes regulate rat granulosa cell steroidogenesis
in vitro. Endocrinology 1988; 123: 2462-71. 32.
Rivier C. Influence of immune signals on the
hypothalamic-pituitary axis of the rodent. Front Neuroendocrinol
1995; 16: 151-82. Fig.
4.- «In vitro» androstenedione release from ovaries of 60-day-old
intact rats stimulated with culture medium of splenocytes from
control (open bars) and SON-t (solid bars) rats. Treatment of
splenocytes with VIP or NPY as well as the number of determinations
and experiments were done as indicated in legend of Fig. 2. A)
Androstenedione ng / mg ovary. B) Androstenedione ng / mg
protein. Values are expressed as the mean ± SEM. Bars sharing a
same superscript letter indicate significant differences at a
p<0.001 as determined by Student’s t- test.
+ VIP
Culture
from
splenocytes
SON-t
rats
+ NPY
from
from
SON-t
control
rats
rats Incubation
of ovaries
Progesterone from
intact rats
Estradiol
Androstenedione Fig.
1.– Diagram of the experimental design. Fig.
2.– «In vitro» progesterone release from ovaries of 60-day-old
intact rats stimulated with culture medium of splenocytes from
control (open bars) and SON-t (solid bars) rats. Secretions from
SON-t rat splenocytes incubated 24 h with and without VIP or NPY,
both at 10 -6M,
and then cultured in fresh medium alone for another 24 h were used. A)
Progesterone ng / mg ovary. B) Progesterone ng / mg protein.
Values are expressed as the mean ± SEM of triplicate determinations
of 2 different experiments, using 4 rats per group per experiment
(total 16 ovaries per group). Bars sharing a same superscript letter
indicate significant differences at a,b,c
p<0.001 as determined by Student’s t- test. Fig.
3.- «In vitro» estradiol release from ovaries of 60-day-old intact
rats stimulated with culture medium of splenocytes from control
(open bars) and SON-t (solid bars) rats. Treatment of splenocytes
with VIP or NPY as well as the number of determinations and
experiments were done as indicated in legend of Fig. 2. A)
Estradiol pg / mg ovary. B)
Estradiol pg / mg protein. Values are expressed as the mean
± SEM. Bars sharing a same superscript letter indicate significant
differences at a,b,c
p<0.001 as determined by Student’s t- test. Received: 4-I-2000 Accepted:
2-XI-2000 *Member
of Research Career of CONICET (Consejo Nacional de Investigaciones
Científicas y Técnicas) Postal
address: Dr. Luis Aguado,
Laboratorio de Biología de la Reproducción, Facultad de Química,
Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco
y Pedernera, 5700 San Luis, Argentina. Fax:
54-2652-430224
e-mail: labir@unsl.edu.ar
|